7
MAY
Reports
Q1, 2024 earnings report expected
SUPN
SUPN
Supernus Pharmaceuticals Inc
32.84
32.84
(0%)
EPS
$0.376667
Estimated Sales
$145.83M
Market Cap
$1.78B
Trade
Mentioned
Supernus Pharmaceuticals Inc
SUPN
1.69 (5.42%)
S
32.87
B
33.01
MarketUpdates
United Kingdom
8 months ago
$SUPN (Supernus Pharmaceuticals Inc) Q1 2024 earnings report is expected to be released
7
MAY
Reports
Q1, 2024 earnings report expected
SUPN
SUPN
Supernus Pharmaceuticals Inc
32.84
32.84
(0%)
EPS
$0.376667
Estimated Sales
$145.83M
Market Cap
$1.78B
Trade
Like CommentShare
1 Mentioned
Supernus Pharmaceuticals Inc
SUPN
Supernus Pharmaceuticals Inc